Tumor cell lipid composition and sensitivity to humoral immune killing. I. Modification of cellular lipid and fatty acid content by metabolic inhibitors and hormones.
D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000032:analysis*; D002308:Cardiolipins; D002417:Cattle; D002784:Cholesterol; D003602:Cytotoxicity, Immunologic; D003609:Dactinomycin / Q000494:pharmacology; D004317:Doxorubicin / Q000494:pharmacology; D005227:Fatty Acids / Q000032:analysis*; D005472:Fluorouracil / Q000494:pharmacology*; D006168:Guinea Pigs; D007328:Insulin / Q000494:pharmacology*; D008055:Lipids / Q000032:analysis*; D008113:Liver Neoplasms / Q000032:analysis*; D008244:Lysophosphatidylcholines; D010713:Phosphatidylcholines
D002308:Cardiolipins; D005227:Fatty Acids; D007328:Insulin; D008055:Lipids; D008244:Lysophosphatidylcholines; D010713:Phosphatidylcholines; D003609:Dactinomycin; D004317:Doxorubicin; D002784:Cholesterol; D005472:Fluorouracil